Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial

Abstract

A significant reduction in the frequency of IR symptom was noticed in group C (4 microg/puff, three times a day for 3 consecutive days) vs controls (p=0.003). No significant difference in side effects was recorded in patients receiving Capsicum therapy with respect to controls.